Rosenberg SA - Search Results

1

Growth of tumor-infiltrating lymphocytes from human solid cancers: summary of a 5-year experience.

Yannelli JR, Hyatt C, McConnell S, Hines K, Jacknin L, Parker L, Sanders M, Rosenberg SA. Yannelli JR, et al. Among authors: rosenberg sa. Int J Cancer. 1996 Feb 8;65(4):413-21. doi: 10.1002/(SICI)1097-0215(19960208)65:4<413::AID-IJC3>3.0.CO;2-#. Int J Cancer. 1996. PMID: 8621219

2

Use of soluble recombinant TNF receptor to improve detection of TNF secretion in cultures of tumor infiltrating lymphocytes.

Hwu P, Schwarz S, Custer M, Smith CA, Mulé JJ, Rosenberg SA. Hwu P, et al. Among authors: rosenberg sa. J Immunol Methods. 1992 Jul 6;151(1-2):139-47. doi: 10.1016/0022-1759(92)90112-7. J Immunol Methods. 1992. PMID: 1321199

3

Gene therapy for cancer.

Rosenberg SA. Rosenberg SA. JAMA. 1992 Nov 4;268(17):2416-9. JAMA. 1992. PMID: 1404800

4

The use of congenitally immunodeficient mice to study human tumor metastases and immunotherapy.

Mulé JJ, Jicha DL, Rosenberg SA. Mulé JJ, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Oct;12(3):196-8. doi: 10.1097/00002371-199210000-00011. J Immunother (1991). 1992. PMID: 1445811

5

Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.

Topalian SL, Hom SS, Kawakami Y, Mancini M, Schwartzentruber DJ, Zakut R, Rosenberg SA. Topalian SL, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Oct;12(3):203-6. doi: 10.1097/00002371-199210000-00013. J Immunother (1991). 1992. PMID: 1445813 Review.

6

A pilot study of the combination of interleukin-2-based immunotherapy and radiation therapy.

Lange JR, Raubitschek AA, Pockaj BA, Spencer WF, Lotze MT, Topalian SL, Yang JC, Rosenberg SA. Lange JR, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Nov;12(4):265-71. doi: 10.1097/00002371-199211000-00007. J Immunother (1991). 1992. PMID: 1477077 Clinical Trial.

7

In vivo administration of recombinant macrophage colony-stimulating factor induces macrophage-mediated antibody-dependent cytotoxicity of tumor cells.

Sanda MG, Bolton E, Mulé JJ, Rosenberg SA. Sanda MG, et al. Among authors: rosenberg sa. J Immunother (1991). 1992 Aug;12(2):132-7. doi: 10.1097/00002371-199208000-00008. J Immunother (1991). 1992. PMID: 1504054

8

In vivo activity of tumor necrosis factor (TNF) mutants. Secretory but not membrane-bound TNF mediates the regression of retrovirally transduced murine tumor.

Karp SE, Hwu P, Farber A, Restifo NP, Kriegler M, Mulé JJ, Rosenberg SA. Karp SE, et al. Among authors: rosenberg sa. J Immunol. 1992 Sep 15;149(6):2076-81. J Immunol. 1992. PMID: 1517571 Free PMC article.

9

Surgical resection of metastatic renal cell carcinoma and melanoma after response to interleukin-2-based immunotherapy.

Sherry RM, Pass HI, Rosenberg SA, Yang JC. Sherry RM, et al. Among authors: rosenberg sa. Cancer. 1992 Apr 1;69(7):1850-5. doi: 10.1002/1097-0142(19920401)69:7<1850::aid-cncr2820690729>3.0.co;2-i. Cancer. 1992. PMID: 1551067 Clinical Trial.

10

Interleukin-7 mediates the generation and expansion of murine allosensitized and antitumor CTL.

Jicha DL, Schwarz S, Mulé JJ, Rosenberg SA. Jicha DL, et al. Among authors: rosenberg sa. Cell Immunol. 1992 Apr 15;141(1):71-83. doi: 10.1016/0008-8749(92)90128-c. Cell Immunol. 1992. PMID: 1555257

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results